These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 9815890

  • 1. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ, Broxterman HJ, Ossenkoppele GJ, Baak JP, Eekman CA, Kuiper CM, Feller N, van Heijningen TH, Klumper E, Pieters R.
    Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
    [Abstract] [Full Text] [Related]

  • 2. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
    Benderra Z, Faussat AM, Sayada L, Perrot JY, Chaoui D, Marie JP, Legrand O.
    Clin Cancer Res; 2004 Dec 01; 10(23):7896-902. PubMed ID: 15585622
    [Abstract] [Full Text] [Related]

  • 3. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R.
    Clin Cancer Res; 1997 Aug 01; 3(8):1419-25. PubMed ID: 9815827
    [Abstract] [Full Text] [Related]

  • 4. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD, Doyle LA, Schiffer CA, Lee EJ, Grant CE, Cole SP, Deeley RG, Yang W, Tong Y.
    Leukemia; 1996 Jan 01; 10(1):48-55. PubMed ID: 8558937
    [Abstract] [Full Text] [Related]

  • 5. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
    Illmer T, Schaich M, Oelschlägel U, Nowak R, Renner U, Ziegs B, Subat S, Neubauer A, Ehninger G.
    Leuk Res; 1999 Jul 01; 23(7):653-63. PubMed ID: 10400187
    [Abstract] [Full Text] [Related]

  • 6. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L, Jarque I, Martín G, Sempere A, González-García Y, Gomis F, Pérez-Sirvent M, De La Rubia J, Sanz MA.
    Haematologica; 1998 Sep 01; 83(9):783-7. PubMed ID: 9825574
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM, Paterakis G, Androutsos G, Anagnostopoulos N, Galanopoulos A, Kalmantis T, Meletis J, Rombos Y, Sagriotis A, Symeonidis A, Tiniakou M, Zoumbos N, Yataganas X.
    Leuk Res; 2002 Feb 01; 26(2):143-54. PubMed ID: 11755464
    [Abstract] [Full Text] [Related]

  • 8. The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
    Brooks TA, O'Loughlin KL, Minderman H, Bundy BN, Ford LA, Vredenburg MR, Bernacki RJ, Priebe W, Baer MR.
    Invest New Drugs; 2007 Apr 01; 25(2):115-22. PubMed ID: 17072745
    [Abstract] [Full Text] [Related]

  • 9. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI, Shman TV, Serhiyenka TF, Savitski VP, Smolnikova VV, Fedasenka UU.
    Hematology; 2009 Aug 01; 14(4):204-12. PubMed ID: 19635183
    [Abstract] [Full Text] [Related]

  • 10. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients.
    Legrand O, Simonin G, Perrot JY, Zittoun R, Marie JP.
    Blood; 1998 Jun 15; 91(12):4480-8. PubMed ID: 9616142
    [Abstract] [Full Text] [Related]

  • 11. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
    Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS, Head DR, Weick J, Grever MR, Appelbaum FR, Willman CL.
    Blood; 1999 Aug 01; 94(3):1086-99. PubMed ID: 10419902
    [Abstract] [Full Text] [Related]

  • 12. Transport proteins in drug resistance: detection and prognostic significance in acute myeloid leukemia.
    Broxterman HJ, Schuurhuis GJ.
    J Intern Med Suppl; 1997 Aug 01; 740():147-51. PubMed ID: 9350197
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
    Borg AG, Burgess R, Green LM, Scheper RJ, Liu Yin JA.
    Br J Haematol; 2000 Jan 01; 108(1):48-54. PubMed ID: 10651723
    [Abstract] [Full Text] [Related]

  • 18. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA, Tsvetaeva DA, Grudinskaja TV.
    Exp Oncol; 2013 Dec 01; 35(4):287-90. PubMed ID: 24382439
    [Abstract] [Full Text] [Related]

  • 19. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
    Grey M, Borg AG, Wood P, Burgess R, Fisher A, Yin JA.
    Leuk Res; 1997 Sep 01; 21(9):867-74. PubMed ID: 9393602
    [Abstract] [Full Text] [Related]

  • 20. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
    van der Kolk DM, de Vries EG, van Putten WJ, Verdonck LF, Ossenkoppele GJ, Verhoef GE, Vellenga E.
    Clin Cancer Res; 2000 Aug 01; 6(8):3205-14. PubMed ID: 10955805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.